These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2902611)

  • 21. Almitrine and peripheral neuropathy.
    Suggett AJ; Jarratt JA; Proctor A; Howard P
    Lancet; 1985 Oct; 2(8459):830-1. PubMed ID: 2864548
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuropathy in chronic obstructive pulmonary disease: a multicentre electrophysiological and clinical study.
    Jarratt JA; Morgan CN; Twomey JA; Abraham R; Sheaff PC; Pilling JB; Payan J; Mitchell JD; Tang O; Arnaud F
    Eur Respir J; 1992 May; 5(5):517-24. PubMed ID: 1319353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic bronchopneumopathies. A new therapeutic approach].
    Chrétien J
    Presse Med; 1984 Oct; 13(34):2043-4. PubMed ID: 6149529
    [No Abstract]   [Full Text] [Related]  

  • 24. Almitrine decreases compliance of pulmonary arteries in COPD.
    Hervé P; Simonneau G; Duroux P
    Chest; 1988 Nov; 94(5):1119-20. PubMed ID: 2903012
    [No Abstract]   [Full Text] [Related]  

  • 25. [Peripheral axonic neuropathy during treatment with almitrine bismesylate (Vectarion). Possible role of wasting].
    Gherardi R; Louarn F; Perrier M; Eizenbaum JF
    J Toxicol Clin Exp; 1985; 5(6):393-7. PubMed ID: 2878072
    [No Abstract]   [Full Text] [Related]  

  • 26. [Peripheral neuropathy associated with chronic obstructive pulmonary disease].
    Poza JJ; Martí-Massó JF
    Neurologia; 1997 Nov; 12(9):389-94. PubMed ID: 9471176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
    Voisin C; Howard P; Ansquer JC
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platypnea induced by worsening of VA/Q inhomogeneity in the sitting position in chronic obstructive lung disease.
    Michel O; Sergysels R; Ham H
    Chest; 1988 May; 93(5):1108-10. PubMed ID: 2896103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of oral almitrine on the sleep apnea syndrome].
    Mangin P; Krieger J; Kurtz D
    Rev Fr Mal Respir; 1983; 11(6):899-906. PubMed ID: 6142508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Action of a respiratory stimulant (S 2620), orally administered, in obstructive bronchopulmonary disease (Statistical study) (author's transl)].
    Neukirch F; Castillon du Perron M; Verdier F; Drutel P; Legrand M; Botto MJ; Lesobre R
    Bull Physiopathol Respir (Nancy); 1974; 10(6):793-800. PubMed ID: 4156914
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of the carotid body on gas exchange during exercise.
    Grassi C; Cerveri I; Rampulla C; Tantucci C; Grassi V
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():191s-194s. PubMed ID: 3690031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)].
    Castaing Y; Manier G; Varène N; Guénard H
    Bull Eur Physiopathol Respir; 1981; 17(6):917-32. PubMed ID: 7032629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesylate].
    González Montaner LJ
    Medicina (B Aires); 1986; 46(6):739-41. PubMed ID: 3306258
    [No Abstract]   [Full Text] [Related]  

  • 34. Peripheral neuropathy in chronic obstructive lung disease.
    Moore N; Lerebours G; Senant J; Ozenne G; David P; Nouvet G
    Lancet; 1985 Dec; 2(8467):1311. PubMed ID: 2866379
    [No Abstract]   [Full Text] [Related]  

  • 35. [Peyronie's disease and peripheral neuropathies].
    Diagne M; Gueye SM; Ba M; Konan PG; Diop AG; Ndiaye MM; Ndiaye IP; Mensah A
    Dakar Med; 1998; 43(2):234-7. PubMed ID: 10797972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The acute effect of a single oral dose of 200 mg almitrine on gas exchange in patients with chronic obstructive bronchitis and emphysema, bronchial asthma and lung fibrosis.
    Magnussen H; Radenbach D; Kiwull-Schöne H
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():211s-214s. PubMed ID: 3690032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of almitrine and oxygen on ventilation and gas exchange in patients with chronic respiratory insufficiency.
    Hawryłkiewicz I; Jedrzejewska-Makowska M; Górecka D; Zieliński J
    Eur J Respir Dis; 1983 Oct; 64(7):512-6. PubMed ID: 6138276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology].
    Mihalţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):209-19. PubMed ID: 2894713
    [No Abstract]   [Full Text] [Related]  

  • 39. [Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease].
    Rubio Terrés C; López Alvarez M; Vargas Castrillón E
    Rev Clin Esp; 1990 Feb; 186(2):84-7. PubMed ID: 2158666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Almitrine per os in the therapy of chronic obstructive bronchopneumopathies].
    Seignalet C; Préfaut C; Gonzales C; Michel FB
    Rev Fr Mal Respir; 1980; 8(6):627-33. PubMed ID: 7027375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.